Given the persistent use of antipsychotics during hospitalization and continued use post discharge, there is a need to consider alternative treatment options. The purpose of this study was to evaluate the use of antipsychotics in a sample of hospitalized older adults living with dementia and determine if exposure to Function Focused Care resulted in a decrease in antipsychotic use between admission, discharge, and 1 month post hospitalization. This was a secondary data analysis using data from the study Testing the Effectiveness of the Function Focused Care for Acute Care Study Using the Evidence Integration Triangle (FFC-AC-EIT). A total of 455 residents from 12 nursing homes in two states were included in the study. Sites were randomized to FFC-AC-EIT versus Education Only. The mean age of the participants was 82 years (Standard deviation [SD] = 8.5) and the majority was female (63%), White older adults (65%), married (36%), with high school or more education (81%), and moderate to severe cognitive impairment based on a Saint Louis University Mental Status Exam score of 7.5 (SD = 6.0). Overall, on admission, 17% were on an antipsychotic medication, at discharge, this increased to 21%, and at 1 month, it decreased to 19%. The repeated-measure analysis showed there was a significant difference in antipsychotic use between treatment groups over time (Pillai’s Trace of .05, F = 8.9, p = .001). The intervention group increased in usage from 15% on admission to 23% at discharge and decreased to 18% at 1-month post discharge. Conversely, the control group remained essentially the same over time at 20% on admission and discharge and 21% at 1-month post discharge. The findings from this study confirm that there continues to be use of antipsychotics during hospital admissions, and individuals are still discharged on these medications and continued on these medications over time. There was no evidence to support the value of our FFC-AC-EIT in terms of decreasing the use of antipsychotics over time. Future research is needed to develop interventions focused on decreasing the use of antipsychotics.
American Geriatrics Society Beers Criteria Update Expert Panel. (2023). American Geriatrics Society 2023 updated AGS Beers Criteria for potentially inappropriate medication use in older adults. Journal of the American Geriatrics Society, 71, 2052–2081.
2.
Andersen-RanbergN.C.PoulsenL.M.PernerA.WetterslevJ.EstrupS.HästbackaJ.MorganM.CiterioG.CaballeroJ.LangeT.KjærM.-B. N.EbdrupB. H.EngstrømJ.OlsenM. H.ColletM. O.MortensenC. B.WeberS.-O.AndreasenA. S.BestleM. H.. . .MathiesenO. (2022). Haloperidol for the treatment of delirium in ICU patients. New England Journal of Medicine, 387(26), 2425–2435.
3.
ChowR.WhitingD.FavrilL.OstinelliE.CiprianiA.FazelS. (2023). An umbrella review of adverse effects associated with antipsychotic medications: The need for complementary study designs. Neuroscience & Biobehavioral Reviews, 155, Article 105454.
4.
ClarkeE.NewmanE.DravidM.RicciardelloM.JonesE.CaudleK.KilshawL.HilmiS.FlickerL. (2024). Assessment and management of delirium in a tertiary hospital—Improvements in cognitive screening and use of non-pharmacological strategies with a multidisciplinary approach. Australasian Journal on Ageing, 43(1), 175–182.
DeclercqT.PetrovicM.AzermaiM.Vander SticheleR.De SutterA. I.van DrielM. L.ChristiaensT. (2013). Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia. The Cochrane Database of Systematic Reviews, 2013(3), CD007726. https://doi.org/10.1002/14651858.CD007726.pub2
7.
DrazichB. (2023). Physical activity and impact on psychological and behavior symptoms associated with dementia. Innovations in Aging, 7(1), 212–217.
8.
GalvinJ.RoeC.PowlishtaK.CoatsS.MuichE.GrantJ.MillerM.StorandtJ.MorrisR. (2005). The AD8, a brief informant interview to detect dementia. Neurology, 65, 559–564.
9.
GeskeyJ.YukselJ.SneadJ.NoviaskyJ.BrummelG.ShippeyE. (2023). Factors associated with acute injurious falls in elderly hospitalized patients: A multicenter descriptive study. Joint Commission Journal on Quality & Patient Safety, 49(11), 604–612.
10.
GrahamF.KellyL.BurmeisterE.HendersonA.BroomeA.HubbardR.GordonE. H. (2024). The impact of a hospital-based special care unit on behavioural and psychological symptoms in older people living with dementia. Age & Ageing, 53(4), 1–12.
11.
GrowdonM.GanS.YaffeK.LeeA.AndersonT.MuenchU., et al. (2023). New psychotropic medication use among Medicare beneficiaries with dementia after hospital discharge. Journal of the American Geriatrics Society, 71, 1134–1144.
12.
HuangY. Y.TengT.ShenX. N.ChenS. D.WangR. Z.ZhangR. Q.DouK. X.ZhongX. L.WangJ.ChenK. L.ZhaoQ. H.TanL.DongQ.ZhouX. Y.YuJ. T. (2022). Pharmacological treatments for psychotic symptoms in dementia: A systematic review with pairwise and network meta-analysis. Ageing Research Reviews, 75, 101568. https://doi.org/10.1016/j.arr.2022.101568
InouyeS. K.BogardusS. T.Jr.BakerD. I.Leo-SummersL.CooneyL. M.Jr. (2000). The hospital elder life program: A model of care to prevent cognitive and functional decline in older hospitalized patients. Hospital Elder Life Program. Journal of the American Geriatrics Society, 48(12), 1697–1706.
15.
InouyeS. K.MarcantonioE.MetzgerE. (2014a). Doing damage in delirium: The hazards of antipsychotic treatment in elderly persons. The Lancet, 1(4), 312–315.
16.
InouyeS. K.WestendorpR.SaczynskiJ. (2014b). Delirium in elderly people. Lancet383, 911–922.
17.
JenraumjitR.SomboonJ.ChainanS.ChuenchomP.WongpakaranN.WongpakaranT. (2021). Drug-related problems of antipsychotics in treating delirium among elderly patients: A real-world observational study. Journal of Clinical Pharmacy & Therapeutics, 46(5), 1274–1280.
18.
KenzoraJ.Lucía Lozano-VicarioL.Zambom-FerraresiF.Sáez de AsteasuM.Galbete-JiménezA.Muñoz-VázquezÁ. J.Cedeno-VelozB. A.De la Casa-MarínA.Ollo-MartínezI.Fernández-IrigoyenJ.SantamaríaE.San Miguel ElcanoR.Ortiz-GómezJ. R.Romero-OrtuñoR.IzquierdoM.Martínez-VelillaN. (2024). Effects of exercise intervention for the management of delirium in hospitalized older adults: A randomized clinical trial. Journal of the American Medical Directors Association, 25(8), Article 104980.
19.
KhanB.PerkinsA.CampbellN.GaoS.FarberM.WangS.KhanS. H.ZarzaurB. L.BoustaniM. A. (2019). Pharmacological management of delirium in the intensive care unit: A randomized pragmatic clinical trial. Journal of the American Geriatrics Society, 67(5), 1057–1065.
20.
KimD.LeeH.PawarA.LeeS.ParkC.LevinR. (2023). Trends in use of antipsychotics and psychoactive drugs in older patients after major surgery. Journal of the American Geriatrics Society, 71, 3755–3767.
21.
LeeD.SlomkowskiM.HeftingN.ChenD.LarsenK. G.KohegyiE.HobartM.CummingsJ. L.GrossbergG. T. (2023). Brexpiprazole for the treatment of agitation in Alzheimer Dementia: A randomized clinical trial. JAMA Neurology, 80(12), 1307–1316. https://doi.org/10.1001/jamaneurol.2023.3810
22.
LevensonS. (2024). Antipsychotics in perspective: Past, present, and future: Article 1 of 3. Journal of the American Medical Directors Association, 15, 1–5.
23.
LonerganE.BrittonA. M.LuxenbergJ.WyllerT. (2007). Antipsychotics for delirium. The Cochrane Database of Systematic Reviews, 2007(2), CD005594. https://doi.org/10.1002/14651858.CD005594.pub2
24.
MaustD. T.KimH. M.SeyfriedL. S.ChiangC.KavanaghJ.SchneiderL. S.KalesH. C. (2015). Antipsychotics, other psychotropics, and the risk of death in patients with dementia: Number needed to harm. JAMA Psychiatry, 72, 438–445.
25.
MorleyJ.TumosaN. (2002). Saint Louis University Mental Status Examination (SLUMS)Aging Successfully, 12(1), Article 4.
26.
NguyenP. V. Q.MalachaneA.MinhT. T. V. (2017). Antipsychotic prescription patterns in the management of delirium symptoms in hospitalized elderly patients. Proceedings of Singapore Healthcare, 26(4), 230–234.
27.
O’BryantS.WaringS.CullumC.HallJ.LacritzL.MassmanP.LupoP.ReischJ.DoodyM. R., & Texas Alzheimer’s Research Consortium. (2008). Staging dementia using clinical dementia rating scale sum of boxes scores. Archives of Neurology, 65(8), 1091–1095.
28.
PfefferR.KurosakiT.HarrahC.ChanceJ.FilosS. (1982). Functional Activities Questionnaire (FAQ, PFAQ). APA PsycTests. https://doi.org/10.1037/t04022-000
29.
QinC.JiangY.LinC.LiA.LiuJ. (2021). Perioperative dexmedetomidine administration to prevent delirium in adults after non-cardiac surgery: Asystematic review and meta-analysis. Journal of Clinical Anesthesiology, 73, Article 110308.
30.
ResnickB.BoltzM.GalikE.KuzmikA.EllisJ.WellsC.ZhuS. (2022). Testing function focused care for acute care using the evidence integration triangle: Protocol description. Research in Nursing and Health, 45(3), 300–313.
31.
ResnickB.BoltzM.GalikE.McPhersonR.KuzmikA.DrazichB.KimN.ZhuS.WellsC. (2024). Implementation of function focused care for acute care using the evidence integration triangle. Journal of the American Geriatrics Society, 73(5), 1388–1397.
32.
RogowskaM.ThorntonM.CreeseB.VelayudhanL.AarslandD.BallardC.TsamakisK.StewartR.MuellerC.(2023). Implications of adverse outcomes associated with antipsychotics in older patients with dementia: A 2011–2022 update. Drugs Aging,40(1), 21–32. https://doi.org/10.1007/s40266-022-00992-5
33.
RussekN.SkappakC.ScheuermeyerF.BrousseauA.McLeodS.MeladyD.SpencerM. (2023). Pharmacological management of agitation and delirium in older adults: A survey of practices in canadian emergency departments. Canadian Geriatrics Journal, 26(3), 405–409.
34.
SchneiderL. S.TariotP. N.DagermanK. S.DavisS. M.HsiaoJ. K.IsmailM. S.LebowitzB. D.LyketsosC. G.RyanJ. M.StroupT. S.SultzerD. L.WeintraubD.LiebermanJ. A., & CATIE-AD Study Group (2006). Effectiveness of atypical antipsychotic drugs in patients with Alzheimer’s disease. The New England Journal of Medicine, 355(15), 1525–1538. https://doi.org/10.1056/NEJMoa061240
35.
SchriverE.De VriesO.Van De VenP.BetP.KamperA.DiepeveenS.van MarumR. J.van StrienA. M.AntenS.LagaayA. M.BoelaartsL.BloemersF. W.KramerM. H. H.NanayakkaraP. W. B. (2018). Haloperidol versus placebo for delirium prevention in acutely hospitalised older at risk patients: A multi-centre double-blind randomised controlled clinical trial. Age & Ageing, 47(1), 48–55.
36.
Senate Committee on Aging. (1975). Nursing home care in the United States: Failure in public policy (Supporter Paper No. e: Drugs in nursing homes: Misuse, high costs and kickbacks, Document 41–557). US Government Printing Office.
37.
StroupT.GrayN. (2018). Management of common adverse effects of antipsychotic medications. World Psychiatry, 17(3), 341–356.
38.
TampiR. R.TampiD. J.BalachandranS.SrinivasanS. (2016). Antipsychotic use in dementia: A systematic review of benefits and risks from meta-analyses. Therapeutic Advances in Chronic Disease, 7, 229–245.
39.
ThanapluetiwongS.RuangritchankulS.SriwannopasO.ChansirikarnjanaS.IttasakulP.NgamkalaT.SukumalinL.CharernwatP.SaranburutK.AssavapokeeT. (2021). Efficacy of quetiapine for delirium prevention in hospitalized older medical patients: A randomized double-blind controlled trial. BMC Geriatrics, 21(1), Article 215.
40.
TimmonsS.Bracken‑ScallyM.Shelly ChakrabortyS.Paul GallagherP.Vida HamiltonV.Emer BegleyE.O’SheaE. (2023). Psychotropic medication prescribing to patients with dementia admitted to acute hospitals in Ireland. Drugs & Aging40, 461–472.
41.
TomlinsonE. J.RawsonH.ManiasE.PhillipsN. N. M.DarzinsP.HutchinsonA. M. (2021). Factors associated with the decision to prescribe and administer antipsychotics for older people with delirium: A qualitative descriptive study. BMJ Open, 11(7), e047247. https://doi.org/10.1136/bmjopen-2020-047247
42.
TomlinsonE. J.SchnitkerL.CaseyP. (2024). Exploring antipsychotic use for delirium management in adults in hospital, sub‑acute rehabilitation and aged care settings: A systematic literature review. Drugs & Aging, 41, 455–486.
43.
YangC. T.WilkinsJ. M.DiCesareE.PritchardK. T.ChenQ.ZhangY.KimD. H.LinK. J. (2025). Health outcomes of discontinuing antipsychotics after hospitalization in older adults. JAMA Psychiatry,82(7):671–680. https://doi.org/10.1001/jamapsychiatry.2025.0702
44.
YunusaI.RashidN.DemosG. N.MahadikB. S.AblerV. C.RajagopalanK. (2022). Comparative outcomes of commonly used off-label atypical antipsychotics in the treatment of dementia-related psychosis: A network meta-analysis. Advances in Therapy, 39(5), 1993–2008. https://doi.org/10.1007/s12325-022-02075-8
45.
ZhangY.WilkinsJ.BaessetteL.YorkC.WongV.LinK. J. (2023). Antipsychotic medication use among older adults following infection-related hospitalization. JAMA Network Open, 6, e230063. https://doi.org/10.1001/jamanetworkopen.2023.0063
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
